Effect of L-Ascorbic Acid on the Oxidative Modification of Apolipoprotein E in Human Very-Low-Density Lipoprotein

Journal of Nutritional Science and Vitaminology

Volumn 50, Issue 1, 2004, Pages 66-68

  Arai, Hirofumi ^a   Nakamura, Kazuyuki ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apolipoprotein E; L ascorbic acid; Oxidation; Radicals; Very low density lipoprotein

Indexed keywords

APOLIPOPROTEIN E; ASCORBIC ACID; FREE RADICAL; HEPARIN; PEROXY RADICAL; PEROXYNITRITE; VERY LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; ARTICLE; BINDING ASSAY; BINDING SITE; CONTROLLED STUDY; HUMAN; IMMUNOBLOTTING; LIPID PEROXIDATION; OXIDATION; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN MODIFICATION;

EID: 1642421815     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.50.66     Document Type: Article

References (19)

1. Steinbrecher UP, Zhung HP, Lougheed M, 1990. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med 9: 155-168.
2. Berliner JA, Heinecke JW. 1996. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20: 707-727.
3. Esterbauer H, Schmidt R, Hayn M. 1997. Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis. Adv Pharmacol 38: 425-456.
4. Steinberg D, 1997. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272: 20963-20966.
5. Mohr D, Stocker R. 1994. Radical-mediated oxidation of isolated human very-low-density lipoprotein. Arterioscler Thromb 14: 1186-1192.
6. Arai H, Kashiwagi S, Nagasaka Y, Uchida K, Hoshii Y, Nakamura K. 1999. Oxidative modification of apolipoprotein E in human very-low-density lipoprotein and its inhibition by glycosaminoglycans. Arch Biochem Biophys 367: 1-8.
7. Weisgraber KH. 1994. Apolipoprotein E: structure-function relationships. Adv Protein Chem 45: 249-302.
8. Mahley RW, Ji ZS, 1999. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 40: 1-16.
9. Stahl W, Sies H. 1997. Antioxidant defense: vitamins E and C and carotenoids. Diabetes 46 (Suppl 2): S14-18.
10. Patel RP, Darley-Usmar VM. 1996. Using peroxynitrite as oxidant with low-density lipoprotein. Methods Enzymol 269: 375-384.
11. Hatch FT. 1968. Practical methods for plasma lipoprotein analysis. Adv Lipid Res 6: 1-68.
12. Arai H, Terao J, Abdalla DS, Suzuki T, Takama K. 1996. Coulometric detection in high-performance liquid chromatographic analysis of cholesteryl ester hydroperoxides. Free Radic Biol Med 20: 365-371.
13. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
14. Nomura S, Kashiwagi S, Ito H, Mimura Y, Nakamura K, 1993. Degradation of librinogen and librin by plasmin and nonplasmin proteases in the chronic subdural hematoma: evaluation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot. Electrophoresis 14: 1318-1321.
15. Mahley RW. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630.
16. Cardin AD, Demeter DA, Weintraub HJ, Jackson RL. 1991. Molecular design and modeling of protein-heparin interactions. Methods Enzymol 203: 556-583.
17. Kato Y, Mori Y, Makino Y, Morimitsu Y, Hiroi S, Ishikawa T, Osawa T. 1999. Formation of Nepsilon- (hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J Biol Chem 274: 20406-20414.
18. Hara S, Tanaka T, Yamada M, Nagasaka Y, Nakamura K. 1997. Oxidative modification of apolipoprotein E and its biological significance. In: Oxygen Homeostasis and Its Dynamics (Ishimura Y, ed). p 631-636. Springer Verlag. Tokyo.
19. Haudin RI, Cohen HJ. 1976. Purification and binding properties of human platelet factor four. J Biol Chem 251: 4273-4282.